OLFACTORY DYSFUNCTION

OLFACTORY DYSFUNCTION was reported 42 times

These drug classes are most commonly taken by patients reporting OLFACTORY DYSFUNCTION:

# Drug Count
0 5-alpha Reductase Inhibitor [EPC] 8
1 Platinum-based Drug [EPC] 4
2 Atypical Antipsychotic [EPC] 3
3 CD20-directed Cytolytic Antibody [EPC] 3
4 Interleukin-4 Receptor alpha Antagonist [EPC] 3
5 Microtubule Inhibitor [EPC] 3
6 Programmed Death Ligand-1 Blocker [EPC] 3
7 CTLA-4-directed Blocking Antibody [EPC] 2
8 GLP-1 Receptor Agonist [EPC] 2
9 Kinase Inhibitor [EPC] 2
10 Nucleoside Metabolic Inhibitor [EPC] 2
11 Prostacyclin Receptor Agonist [EPC] 2
12 Soluble Guanylate Cyclase Stimulator [EPC] 2
13 Aldosterone Antagonist [EPC] 1
14 Alkylating Drug [EPC] 1
15 Angiotensin 2 Receptor Blocker [EPC] 1
16 Anti-epileptic Agent [EPC] 1
17 BCL-2 Inhibitor [EPC] 1
18 Benzodiazepine [EPC] 1
19 Calcium Channel Blocker [EPC] 1
20 Cholinergic Muscarinic Antagonist [EPC] 1
21 Corticosteroid [EPC] 1
22 Dihydropyridine Calcium Channel Blocker [EPC] 1
23 Erythropoiesis-stimulating Agent [EPC] 1
24 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
25 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
26 Leukotriene Receptor Antagonist [EPC] 1
27 Macrolide Antimicrobial [EPC] 1
28 Melanocortin 4 Receptor Agonist [EPC] 1
29 Mood Stabilizer [EPC] 1
30 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1
32 Orexin Receptor Antagonist [EPC] 1
33 P2Y12 Platelet Inhibitor [EPC] 1
34 Phosphodiesterase 5 Inhibitor [EPC] 1
35 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
36 Proton Pump Inhibitor [EPC] 1
37 Purine Antimetabolite [EPC] 1
38 RNA Synthetase Inhibitor Antibacterial [EPC] 1
39 Serotonin-3 Receptor Antagonist [EPC] 1
40 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
41 Thalidomide Analog [EPC] 1
42 Tyrosine Kinase 2 Inhibitor [EPC] 1
43 Vasopressin V2 Receptor Antagonist [EPC] 1
44 Xanthine Oxidase Inhibitor [EPC] 1